TRxADE HEALTH, Inc. (MEDS) |
| 7.59 0.33 (4.55%) 09-20 16:00 |
| Open: | 7.25 |
| High: | 7.7 |
| Low: | 7.06 |
| Volume: | 18,992 |
| Market Cap: | 13(M) |
| PE Ratio: | -0.31 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Pharmaceuticals |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 9.55 |
| Resistance 1: | 8.38 |
| Pivot price: | 8.07 |
| Support 1: | 6.50 |
| Support 2: | 5.41 |
| 52w High: | 44.56 |
| 52w Low: | 3.69 |
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Financials
| EPS | -12040000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 56.68 |
| Operating Margin (%) | -7.00 |
| Return on Assets (ttm) | 998.8 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 25 Apr 2025
TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC. - ACCESS Newswire
Tue, 24 Sep 2024
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
Mon, 05 Aug 2024
Whittier Daily News - FinancialContent
Fri, 26 Jul 2024
Whittier Daily News - FinancialContent
Fri, 26 Jul 2024
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - GlobeNewswire
Fri, 16 Feb 2024
Dykema Completes Sale of Assets for TRxADE Health, Inc. - Dykema
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
